Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

OSL:BAKKA - Euronext Oslo - FO0000000179 - Common Stock - Currency: NOK

521.5  +2.5 (+0.48%)

Fundamental Rating

6

Taking everything into account, BAKKA scores 6 out of 10 in our fundamental rating. BAKKA was compared to 58 industry peers in the Food Products industry. BAKKA has an excellent financial health rating, but there are some minor concerns on its profitability. BAKKA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
In the past year BAKKA had a positive cash flow from operations.
In the past 5 years BAKKA has always been profitable.
In the past 5 years BAKKA always reported a positive cash flow from operatings.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

BAKKA has a Return On Assets of 3.72%. This is comparable to the rest of the industry: BAKKA outperforms 50.00% of its industry peers.
BAKKA has a Return On Equity (5.88%) which is in line with its industry peers.
With a Return On Invested Capital value of 6.24%, BAKKA perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BAKKA is in line with the industry average of 7.19%.
Industry RankSector Rank
ROA 3.72%
ROE 5.88%
ROIC 6.24%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of BAKKA (8.95%) is better than 75.86% of its industry peers.
BAKKA's Profit Margin has declined in the last couple of years.
BAKKA's Operating Margin of 18.10% is amongst the best of the industry. BAKKA outperforms 86.21% of its industry peers.
In the last couple of years the Operating Margin of BAKKA has declined.
With an excellent Gross Margin value of 69.93%, BAKKA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
BAKKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.1%
PM (TTM) 8.95%
GM 69.93%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BAKKA is destroying value.
BAKKA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BAKKA has more shares outstanding
BAKKA has a better debt/assets ratio than last year.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

BAKKA has an Altman-Z score of 3.24. This indicates that BAKKA is financially healthy and has little risk of bankruptcy at the moment.
BAKKA's Altman-Z score of 3.24 is fine compared to the rest of the industry. BAKKA outperforms 77.59% of its industry peers.
BAKKA has a debt to FCF ratio of 2.84. This is a good value and a sign of high solvency as BAKKA would need 2.84 years to pay back of all of its debts.
BAKKA has a Debt to FCF ratio of 2.84. This is amongst the best in the industry. BAKKA outperforms 84.48% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that BAKKA is not too dependend on debt financing.
BAKKA has a better Debt to Equity ratio (0.33) than 77.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.84
Altman-Z 3.24
ROIC/WACC0.78
WACC7.99%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 6.75 indicates that BAKKA has no problem at all paying its short term obligations.
BAKKA has a better Current ratio (6.75) than 98.28% of its industry peers.
A Quick Ratio of 1.78 indicates that BAKKA should not have too much problems paying its short term obligations.
The Quick ratio of BAKKA (1.78) is better than 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 6.75
Quick Ratio 1.78
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.61% over the past year.
BAKKA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.36% yearly.
BAKKA shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
The Revenue has been growing by 10.21% on average over the past years. This is quite good.
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%22.75%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-5.9%

3.2 Future

BAKKA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.37% yearly.
Based on estimates for the next years, BAKKA will show a quite strong growth in Revenue. The Revenue will grow by 11.35% on average per year.
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue Next Year3.47%
Revenue Next 2Y11.72%
Revenue Next 3Y11.35%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.87, BAKKA is valued on the expensive side.
BAKKA's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of BAKKA to the average of the S&P500 Index (27.85), we can say BAKKA is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.99, BAKKA is valued correctly.
BAKKA's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 20.77. BAKKA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.87
Fwd PE 14.99
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BAKKA is valued a bit more expensive than 60.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BAKKA is valued a bit cheaper than 63.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.71
EV/EBITDA 11.24
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of BAKKA may justify a higher PE ratio.
A more expensive valuation may be justified as BAKKA's earnings are expected to grow with 26.37% in the coming years.
PEG (NY)0.93
PEG (5Y)N/A
EPS Next 2Y26.38%
EPS Next 3Y26.37%

4

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.60%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.09, BAKKA has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, BAKKA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.6%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

BAKKA pays out 78.48% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BAKKA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP78.48%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (4/30/2025, 7:00:00 PM)

521.5

+2.5 (+0.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-17 2025-02-17/bmo
Earnings (Next)05-19 2025-05-19
Inst Owners63%
Inst Owner ChangeN/A
Ins Owners16.05%
Ins Owner ChangeN/A
Market Cap30.92B
Analysts76.67
Price Target661.53 (26.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.6%
Yearly Dividend13.79
Dividend Growth(5Y)3.15%
DP78.48%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.95%
Min EPS beat(2)-51.09%
Max EPS beat(2)-2.8%
EPS beat(4)1
Avg EPS beat(4)-18.91%
Min EPS beat(4)-51.09%
Max EPS beat(4)1.9%
EPS beat(8)3
Avg EPS beat(8)-12.34%
EPS beat(12)3
Avg EPS beat(12)-14.45%
EPS beat(16)4
Avg EPS beat(16)-16.18%
Revenue beat(2)0
Avg Revenue beat(2)-15.63%
Min Revenue beat(2)-18.93%
Max Revenue beat(2)-12.34%
Revenue beat(4)1
Avg Revenue beat(4)-9.34%
Min Revenue beat(4)-18.93%
Max Revenue beat(4)2.47%
Revenue beat(8)2
Avg Revenue beat(8)-4.31%
Revenue beat(12)5
Avg Revenue beat(12)-2.7%
Revenue beat(16)6
Avg Revenue beat(16)-2.83%
PT rev (1m)-5.43%
PT rev (3m)-13.5%
EPS NQ rev (1m)-24.49%
EPS NQ rev (3m)-41.18%
EPS NY rev (1m)-3.06%
EPS NY rev (3m)-14.73%
Revenue NQ rev (1m)-2.68%
Revenue NQ rev (3m)-21.79%
Revenue NY rev (1m)-3.43%
Revenue NY rev (3m)-10.9%
Valuation
Industry RankSector Rank
PE 17.87
Fwd PE 14.99
P/S 2.67
P/FCF 14.71
P/OCF 8.3
P/B 1.75
P/tB 2.94
EV/EBITDA 11.24
EPS(TTM)29.19
EY5.6%
EPS(NY)34.8
Fwd EY6.67%
FCF(TTM)35.45
FCFY6.8%
OCF(TTM)62.83
OCFY12.05%
SpS195.67
BVpS297.91
TBVpS177.37
PEG (NY)0.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.72%
ROE 5.88%
ROCE 7.85%
ROIC 6.24%
ROICexc 6.42%
ROICexgc 8.86%
OM 18.1%
PM (TTM) 8.95%
GM 69.93%
FCFM 18.12%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexcg growth 3Y13.09%
ROICexcg growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score6
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 2.84
Debt/EBITDA 1.83
Cap/Depr 145.7%
Cap/Sales 13.99%
Interest Coverage 250
Cash Conversion 115.89%
Profit Quality 202.37%
Current Ratio 6.75
Quick Ratio 1.78
Altman-Z 3.24
F-Score6
WACC7.99%
ROIC/WACC0.78
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.61%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%22.75%
EPS Next Y19.21%
EPS Next 2Y26.38%
EPS Next 3Y26.37%
EPS Next 5YN/A
Revenue 1Y (TTM)2.7%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-5.9%
Revenue Next Year3.47%
Revenue Next 2Y11.72%
Revenue Next 3Y11.35%
Revenue Next 5YN/A
EBIT growth 1Y-4.55%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year76.1%
EBIT Next 3Y34.81%
EBIT Next 5YN/A
FCF growth 1Y3475.19%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y130.26%
OCF growth 3Y27.94%
OCF growth 5Y17.84%